Dunmore Senior Living of Oxford

The facility failed to ensure quarterly Licensed Health Professional Support (LHPS) evaluations were completed for residents requiring specific medical tasks. Specifically, two residents receiving fingerstick blood sugar checks, insulin injections, and ambulation assistance with a walker lacked required quarterly evaluations by a licensed nurse.

The facility failed to ensure quarterly Licensed Professional Health Support (LHPS) evaluations were completed by a nurse for two sampled residents. These residents required specific clinical tasks, including fingerstick blood sugar checks, insulin injections, and assistance with ambulation.

The facility failed to administer medications as ordered for one resident regarding a stool softener and a laxative. Specifically, an observation of medication on hand revealed two full 16-ounce bottles of docusate sodium, indicating the medication was not being administered as prescribed in the resident's record.

The facility failed to provide necessary personal care to a resident whose toenails were broken, jagged, and long with tannish crustation. Staff failed to monitor or provide nail care despite the resident's need and the requirement to provide supervision in accordance with assessed needs.

The facility failed to provide necessary personal care to a resident who required toenail trimming. Observations revealed broken, jagged, and overgrown toenails with crustation on both feet. The resident reported that his nails had not been cut in several months and that a request for care made on 08/01/23 had not been addressed.

The facility failed to administer medications as ordered for a resident, specifically regarding eye drops and a topical pain cream. Record reviews of Resident #4's eMAR showed missed doses of Restasis eye drops on multiple dates in December 2021.

The facility failed to administer medications as ordered for one resident, specifically regarding eye drops and a topical cream. Review of the electronic medication administration record (eMAR) and pharmacy records showed missed doses and undocumented administrations of Restasis 0.05% eye drops. Additionally, pharmacy records indicated no re-order was placed for the medication in November 2021, despite the supply being insufficient to cover that period.

The facility failed to ensure the electronic medication administration record (eMAR) was accurate for 2 of 6 sampled residents. Specifically, the eMAR continued to document the administration of a discontinued anti-hypertension medication for one resident and documented a blood thinner as administered when it was not available for use.